InhibOx, an Oxford, UK-based drug discovery service provider, said last week that it is teaming up with the non-profit Cambridge Crystallographic Data Centre in order to offer computer-aided drug discovery services.

The partners said they plan to offer customers a range of computational drug design services, including receptor site modeling, lead identification, lead optimization, ADME property prediction, and formulation modeling.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.